277 related articles for article (PubMed ID: 15690474)
1. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.
Sirica AE
Hepatology; 2005 Jan; 41(1):5-15. PubMed ID: 15690474
[TBL] [Abstract][Full Text] [Related]
2. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
Demols A; Maréchal R; Devière J; Van Laethem JL
Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
[TBL] [Abstract][Full Text] [Related]
3. The molecular pathogenesis of cholangiocarcinoma.
Berthiaume EP; Wands J
Semin Liver Dis; 2004 May; 24(2):127-37. PubMed ID: 15192786
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy in cholangiocarcinomas.
Ortner MA
Best Pract Res Clin Gastroenterol; 2004 Feb; 18(1):147-54. PubMed ID: 15123089
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinoma and the role of radiation and chemotherapy.
Price P
Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
[TBL] [Abstract][Full Text] [Related]
6. Akt expression may predict favorable prognosis in cholangiocarcinoma.
Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for cholangiocarcinoma.
Ortner MA
Lasers Surg Med; 2011 Sep; 43(7):776-80. PubMed ID: 22057505
[TBL] [Abstract][Full Text] [Related]
8. Technology insight: Photodynamic therapy for cholangiocarcinoma.
Ortner MA; Dorta G
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):459-67. PubMed ID: 16883350
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Ortner MA
Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma.
Patel T
Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for cholangiocarcinoma.
Berr F
Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma.
Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
[TBL] [Abstract][Full Text] [Related]
15. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
[TBL] [Abstract][Full Text] [Related]
17. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
Wu T
Biochim Biophys Acta; 2005 Jul; 1755(2):135-50. PubMed ID: 15921858
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
Zheng J; Zhu YM
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.
Sirica AE; Lai GH; Endo K; Zhang Z; Yoon BI
Semin Liver Dis; 2002 Aug; 22(3):303-13. PubMed ID: 12360423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
